Search results

5 items
  1. Statement about the coca leaf

    11 March 2008
    Declaration

    Statement in support of the Bolivian announcement to ask for the un-scheduling of the coca leaf from the list controlled substances of the 1961 UN Single Convention.

    Transnational Institute / International Drug Policy Consortium (IDCP)

    March 12, 2008

     

  2. Video report of the UN drug debate

    Drugreporter HCLU
    08 April 2015
    Multi-media

    This March, our video advocacy team attended the 58th session of the Commission on Narcotic Drugs, the largest drug policy gathering in the world, to find out how governments and NGOs feel about the prospects of drug policy reform. We produced a series of short thematic videos, to give you an overview of the current state of political debate on the burning issues of international drug control.

  3. The UNGASS outcome document: Diplomacy or denialism?

    14 March 2016
    Declaration

    Drug policy experts and impacted communities from around the world express serious concerns about the preparations and already-drafted outcomes for the UN General Assembly Special Session (UNGASS) on the “world drug problem”.

  4. Regulating cannabis in accordance with international law

    22 March 2018
    Multi-media

    As a growing number of countries move towards legal regulation for non-medical cannabis, governments are pushing the boundaries of the three UN drug control treaties. At the 61st session of the Commission on Narcotic Drugs (CND), TNI co-organised a side event to explore the issue, addressing the various challenges and opportunities involved.

  5. Myanmar Opium Farmers Forum at the Commission on Narcotic Drugs in October 2018

    Myanmar Opium Farmers Forum (MOFF)
    30 October 2018
    Multi-media

    The voice of communities involved in illicit cultivation had long been excluded from policymaking platforms. However, thanks to growing networks such as the Myanmar Opium Farmers Forum, more and more farmers have gained more space to provide input to drug policy discussions at the UN level.